Copyright
©The Author(s) 2024.
World J Transplant. Mar 18, 2024; 14(1): 88833
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.88833
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.88833
Table 2 Indications of transarterial chemoembolization, transarterial radioembolization and stereotactic body radiotherapy in hepatocellular carcinoma–chronic liver disease patients awaiting liver transplantation
Modality | TACE | TARE | SBRT |
Indications (No. Of centers preferred) | HCC patients on waitlist[12] | PVTT[12] | Vp1-3 PVTT[12] |
> Milan[4] | Large/multiple HCC[6] | Vp2 PVTT[2] | |
> UCSF[2] | All affordable cases[3] | TACE/TARE not possible[4] | |
Large tumor size[13] | Exophytic HCC[1] | ||
Awaiting donor fitness/logistical delay in transplant[2] | Diaphragm involved or local infiltration[1] | ||
High AFP[5] | Presence of shunt[1] | ||
Absence of PVTT[2] | Not preferred[3] | ||
TARE unaffordable/unavailable[4] |
- Citation: Pahari H, Raj A, Sawant A, Ahire DS, Rathod R, Rathi C, Sankalecha T, Palnitkar S, Raut V. Liver transplantation for hepatocellular carcinoma in India: Are we ready for 2040? World J Transplant 2024; 14(1): 88833
- URL: https://www.wjgnet.com/2220-3230/full/v14/i1/88833.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i1.88833